Korro Bio, Inc.
Price Action
Technical Summary
EMERGING TRENDKorro Bio, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is weak (RS Rating: 48), showing significant lag compared to the market leaders. Earnings growth of 32% provides fundamental context to the price action. Investors should exercise caution due to high volatility (125% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $11.85 | +11.36% | ABOVE |
| 50 SMA | $12.18 | +8.37% | ABOVE |
| 100 SMA | $12.08 | +9.24% | ABOVE |
| 150 SMA | $10.87 | +21.43% | ABOVE |
| 200 SMA | $17.15 | -23.06% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is KRRO in an uptrend right now?
KRRO has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is KRRO overbought or oversold?
KRRO's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is KRRO outperforming the market?
KRRO has a Relative Strength (RS) Rating of 48 out of 99. KRRO is currently lagging the broader market.
Where is KRRO in its 52-week range?
KRRO is trading at $13.20, which is 24% of its 52-week high ($55.89) and 16% above its 52-week low ($5.20).
How volatile is KRRO?
KRRO has a Beta of 3.20 and 52-week volatility of 125%. It's more volatile than the S&P 500 - expect bigger swings.